Terms: = Sarcomas AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL AND Prognosis
16 results:
1. Bioinformatics and Experimental Validation for Identifying Biomarkers Associated with AMG510 (Sotorasib) Resistance in KRAS
Lin P; Cheng W; Qi X; Zhang P; Xiong J; Li J
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338834
[TBL] [Abstract] [Full Text] [Related]
2. Platinum-Based Regimens Are Active in Advanced Pediatric-Type Rhabdomyosarcoma in Adults and Depending on HMGB1 Expression.
Hindi N; Carrillo-García J; Blanco-Alcaina E; Renshaw M; Luna P; Durán J; Jiménez N; Sancho P; Ramos R; Moura DS; Martín-Broto J
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614297
[TBL] [Abstract] [Full Text] [Related]
3. Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma.
Jagosky MH; Anderson CJ; Symanowski JT; Steuerwald NM; Farhangfar CJ; Baldrige EA; Benbow JH; Livingston MB; Patt JC; Ahrens WA; Kneisl JS; Kim ES
Cancer Med; 2023 Mar; 12(6):7029-7038. PubMed ID: 36464833
[TBL] [Abstract] [Full Text] [Related]
4. Expression and Clinical Significance of High-Mobility Group AT-hook 2 (hmga2) in Osteosarcoma.
Cui J; Dean D; Hornicek FJ; Yi G; Duan Z
Orthop Surg; 2022 May; 14(5):955-966. PubMed ID: 35388973
[TBL] [Abstract] [Full Text] [Related]
5. Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult Rhabdomyosarcomas.
De Vita A; Vanni S; Fausti V; Cocchi C; Recine F; Miserocchi G; Liverani C; Spadazzi C; Bassi M; Gessaroli M; Campobassi A; De Luca G; Pieri F; Farnedi A; Franchini E; Ferrari A; Domizio C; Cavagna E; Gurrieri L; Bongiovanni A; Riva N; Calpona S; Di Menna G; Debonis SA; Ibrahim T; Mercatali L
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768995
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic significance of the MDM2/hmga2 ratio and histological tumor grade in dedifferentiated liposarcoma.
Yamashita K; Kohashi K; Yamada Y; Akatsuka S; Ikuta K; Nishida Y; Toyokuni S; Oda Y
Genes Chromosomes Cancer; 2021 Jan; 60(1):26-37. PubMed ID: 33111425
[TBL] [Abstract] [Full Text] [Related]
7. The transcribed pseudogene RPSAP52 enhances the oncofetal hmga2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition.
Oliveira-Mateos C; Sánchez-Castillo A; Soler M; Obiols-Guardia A; Piñeyro D; Boque-Sastre R; Calleja-Cervantes ME; Castro de Moura M; Martínez-Cardús A; Rubio T; Pelletier J; Martínez-Iniesta M; Herrero-Martín D; Tirado OM; Gentilella A; Villanueva A; Esteller M; Farré L; Guil S
Nat Commun; 2019 Sep; 10(1):3979. PubMed ID: 31484926
[TBL] [Abstract] [Full Text] [Related]
8. Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas.
Yang X; Huang WT; He RQ; Ma J; Lin P; Xie ZC; Ma FC; Chen G
J Transl Med; 2019 Aug; 17(1):283. PubMed ID: 31443718
[TBL] [Abstract] [Full Text] [Related]
9. Knockdown of hmga2 regulates the level of autophagy via interactions between MSI2 and Beclin1 to inhibit NF1-associated malignant peripheral nerve sheath tumour growth.
Yang K; Guo W; Ren T; Huang Y; Han Y; Zhang H; Zhang J
J Exp Clin Cancer Res; 2019 May; 38(1):185. PubMed ID: 31053152
[TBL] [Abstract] [Full Text] [Related]
10. Myxoid leiomyosarcoma of the uterus: a clinicopathological and immunohistochemical study of 10 cases.
Lu B; Shi H; Zhang X
Hum Pathol; 2017 Jan; 59():139-146. PubMed ID: 27717885
[TBL] [Abstract] [Full Text] [Related]
11. Genomewide copy number analysis of Müllerian adenosarcoma identified chromosomal instability in the aggressive subgroup.
Lee JC; Lu TP; Changou CA; Liang CW; Huang HN; Lauria A; Huang HY; Lin CY; Chiang YC; Davidson B; Lin MC; Kuo KT
Mod Pathol; 2016 Sep; 29(9):1070-82. PubMed ID: 27255164
[TBL] [Abstract] [Full Text] [Related]
12. Uterine adenosarcomas are mesenchymal neoplasms.
Piscuoglio S; Burke KA; Ng CK; Papanastasiou AD; Geyer FC; Macedo GS; Martelotto LG; de Bruijn I; De Filippo MR; Schultheis AM; Ioris RA; Levine DA; Soslow RA; Rubin BP; Reis-Filho JS; Weigelt B
J Pathol; 2016 Feb; 238(3):381-8. PubMed ID: 26592504
[TBL] [Abstract] [Full Text] [Related]
13. Peritoneal sarcomatosis: site of origin for the establishment of an in vitro and in vivo cell line model to study therapeutic resistance in dedifferentiated liposarcoma.
Mersch S; Riemer JC; Schlünder PM; Ghadimi MP; Ashmawy H; Möhlendick B; Topp SA; Arent T; Kröpil P; Stoecklein NH; Gabbert HE; Knoefel WT; Krieg A
Tumour Biol; 2016 Feb; 37(2):2341-51. PubMed ID: 26373732
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic value of hmga2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas.
Saâda-Bouzid E; Burel-Vandenbos F; Ranchère-Vince D; Birtwisle-Peyrottes I; Chetaille B; Bouvier C; Château MC; Peoc'h M; Battistella M; Bazin A; Gal J; Michiels JF; Coindre JM; Pedeutour F; Bianchini L
Mod Pathol; 2015 Nov; 28(11):1404-14. PubMed ID: 26336885
[TBL] [Abstract] [Full Text] [Related]
15. Increased expression of Lin28B associates with poor prognosis in patients with oral squamous cell carcinoma.
Wu T; Jia J; Xiong X; He H; Bu L; Zhao Z; Huang C; Zhang W
PLoS One; 2013; 8(12):e83869. PubMed ID: 24386298
[TBL] [Abstract] [Full Text] [Related]
16. Molecules involved in epithelial-mesenchymal transition and epithelial-stromal interaction in phyllodes tumors: implications for histologic grade and prognosis.
Kwon JE; Jung WH; Koo JS
Tumour Biol; 2012 Jun; 33(3):787-98. PubMed ID: 22203494
[TBL] [Abstract] [Full Text] [Related]
